Eczema treatment cuts risk of death from COVID-19, study suggests
A monoclonal antibody used to treat asthma and eczema can improve survival for patients with moderate to severe COVID-19, a clinical trial suggests.
A monoclonal antibody used to treat asthma and eczema can improve survival for patients with moderate to severe COVID-19, a clinical trial suggests.
A possible way to tackle one of the underlying causes of asthma has been developed. In tests in mice, the researchers were able to virtually
The different geographic and climatic regions from which ragweed pollen originates, as well as the degree of environmental pollution, may influence the severity of allergic
Early exposure to antibiotics kills healthy bacteria in the digestive tract and can cause asthma and allergies, a new study demonstrates.
Hospital readmissions for asthma are increasing among children, according to a new study, highlighting the gaps in health care for the most common chronic pediatric